3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Leukemia
3
Thalassemia
2
Primary Immunodeficiency Diseases
2
Multiple Myeloma
2
Hemoglobinopathies
2
Hematologic Neoplasms
2
Fanconi Anemia
2
Cytopenia
2
Anemia, Sickle Cell
2
Anemia, Diamond-Blackfan
2
Anemia, Aplastic
2
Anemia
2
Uveal Melanoma
1
Recurrence
1
Osteopetrosis
1
Neoplasms, Plasma Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Interventions
Cyclophosphamide
21
Isotretinoin
14
Etoposide
13
Topotecan
12
Irinotecan
12
dinutuximab
10
Temozolomide
10
Magnetic Resonance Spectroscopy
10
Doxorubicin
10
Melphalan
9
sargramostim
8
Vincristine
8
Filgrastim
7
Cisplatin
7
Specimen Handling
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Granulocyte Colony-Stimulating Factor
6
Carboplatin
6
3-Iodobenzylguanidine
6
X-Rays
5
Phantoms, Imaging
5
Busulfan
5
Biopsy
5
fludarabine
4
etoposide phosphate
4
aldesleukin
4
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroblastoma
×
AP 1903 reagent
×
Clear all
No trials found.